BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6134009)

  • 1. Catecholamine suppression testing in patient with phaechromocytoma and normal plasma catecholamine levels.
    Levinson PD; Lance BK; Kowarski AA; Hamilton BP
    Lancet; 1983 May; 1(8335):1216-7. PubMed ID: 6134009
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.
    Plewe G; Krause U; Cordes U; Beyer J
    Klin Wochenschr; 1988 Sep; 66(17):764-7. PubMed ID: 3184760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case.
    Dupont AG; Vanderniepen P; Gerlo E; Somers G; Vanhaelst L; in't Veld P; Gepts W; Sacre R; Six RO
    J Endocrinol Invest; 1985 Apr; 8(2):153-6. PubMed ID: 4031382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels.
    Elliott WJ; Murphy MB
    Am J Med; 1988 Mar; 84(3 Pt 1):419-24. PubMed ID: 3348244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine suppression test for pheochromocytoma: examples of misleading results.
    Taylor HC; Mayes D; Anton AH
    J Clin Endocrinol Metab; 1986 Jul; 63(1):238-42. PubMed ID: 3711261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.
    Mannelli M; De Feo ML; Maggi M; Pupilli C; Opocher G; Valenza T; Baldi E; Serio M
    J Endocrinol Invest; 1987 Aug; 10(4):377-82. PubMed ID: 2890684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.
    Bravo EL; Tarazi RC; Fouad FM; Vidt DG; Gifford RW
    N Engl J Med; 1981 Sep; 305(11):623-6. PubMed ID: 7266587
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
    Zweifler AJ; Julius S
    N Engl J Med; 1982 Apr; 306(15):890-4. PubMed ID: 7062972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Test with clonidine for diagnosing pheochromocytoma].
    Wocial B; Chojnowski K; Chodakowska J; Feltynowski T; Lazecki D; Januszewicz W
    Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):641-5. PubMed ID: 1845684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
    Koshida H; Miyamori I; Soma R; Matsubara T; Okamoto S; Ikeda M; Takeda R
    J Endocrinol Invest; 1990 Nov; 13(10):807-15. PubMed ID: 2096157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine suppression test revisited.
    Lenz T; Ross A; Schumm-Draeger P; Schulte KL; Geiger H
    Blood Press; 1998 May; 7(3):153-9. PubMed ID: 9758085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the clonidine suppression test in the diagnosis of pheochromocytoma.
    Karlberg BE; Hedman L
    Acta Med Scand Suppl; 1986; 714():15-21. PubMed ID: 3472437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma norepinephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas.
    Levinson PD; Hamilton BP; Mersey JH; Kowarski AA
    Metabolism; 1983 Oct; 32(10):998-1001. PubMed ID: 6888268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topical diagnosis of chromaffin tumors based on the catecholamine content of selected plasma specimens].
    Iurginov OG; Komissarenko IV; Bezverkhaia TP; Makarenko GI
    Probl Endokrinol (Mosk); 1982; 28(3):24-9. PubMed ID: 7100129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma.
    Pontremoli R; Borgonovo G; Ranise A; Garibotto G
    J Endocrinol Invest; 1989 Oct; 12(9):647-9. PubMed ID: 2685095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and clinical observations with a two-column plasma catecholamine assay.
    Jiang NS; Stoffer SS; Pikler GM; Wadel O; Sheps SG
    Mayo Clin Proc; 1973 Jan; 48(1):47-9. PubMed ID: 4683698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma].
    Stimpel M; Schürmeyer T; Ivens K; Wambach G; Volkmann HP; von zur Mühlen A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):130-4. PubMed ID: 3338391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertension.
    Bachmann AW; Gordon RD
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):275-7. PubMed ID: 2065469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results with the clonidine suppression test in the diagnosis of pheochromocytoma.
    Brandstetter K; Krause U; Beyer J
    Cardiology; 1985; 72 Suppl 1():157-9. PubMed ID: 4053124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine measurements in clinical medicine.
    Brown MJ
    Postgrad Med J; 1983 Aug; 59(694):479-82. PubMed ID: 6353395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.